|Year : 2022 | Volume
| Issue : 4 | Page : 209-214
Antrodia salmonea extract inhibits cell proliferation through regulating cell cycle arrest and apoptosis in prostate cancer cell lines
Pang-Ting Cheng1, Yu-Chiao Cheng1, Muhammet Oner1, Yu-Hsuan Li2, Mei-Chih Chen3, Jyh-Horng Wu4, Ting-Chieh Chang1, Ayse Celik1, Fang-Ling Liu1, Hsin-Yi Wang5, Chih-Ho Lai6, Jer-Tsong Hsieh7, Chieh-Yin Chen8, Ho Lin9
1 Department of Life Sciences, National Chung Hsing University, Taichung City, Taiwan
2 Department of Life Sciences, National Chung Hsing University, Taichung City; Translational Cell Therapy Center, Department of Medical Research, China Medical University Hospital, Taichung City, Taiwan
3 Translational Cell Therapy Center, Department of Medical Research, China Medical University Hospital, Taichung City, Taiwan
4 Department of Forestry, National Chung Hsing University, Taichung City, Taiwan
5 Department of Nuclear Medicine, Taichung Veterans General Hospital, Taichung City, Taiwan
6 Department of Microbiology and Immunology, Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan City, Taiwan
7 Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA
8 Experimental Forest, College of Bio-Resources and Agriculture, National Taiwan University, Taichung City, Taiwan
9 Department of Life Sciences; Ph.D. Program in Translational Medicine; Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung City, Taiwan
|Date of Submission||07-Sep-2021|
|Date of Decision||23-May-2022|
|Date of Acceptance||02-Jun-2022|
|Date of Web Publication||26-Aug-2022|
Dr. Chieh-Yin Chen
Experimental Forest, College of Bio-Resources and Agriculture, National Taiwan University, Taichung City
Prof. Ho Lin
Department of Life Sciences, National Chung Hsing University, Taichung City
Source of Support: None, Conflict of Interest: None
Antrodia salmonea (AS) is a fungus, which belongs to a fungal family of Taiwanofungus salmoneus with the features of anti-oxidant, anti-inflammatory, and anticancer. Recent studies have shown that AS has anti-cancer functions in ovarian and breast cancer. However, the effects of AS on prostate cancer (PCa) proliferation remain unknown. Therefore, we investigated the role of AS in PCa proliferation through apoptosis, and cell cycle regulation in PCa cell lines. Our results showed that Antrodia salmonea extract (ASE) inhibited PCa cells growth with a dose-dependent manner. In addition, ASE decreased the anchorage-independent growth formation ability in PC3 cells. Moreover, ASE-induced cell growth inhibition in PCa cells (DU145, PC3) was correlated to decreased cell cycle-related proteins such as cyclin A/B and cyclin-dependent kinase CDK1/2/4, and increased cell cycle inhibitor proteins p21. Besides, ASE decreased the total protein level of epidermal growth factor receptor and its downstream signaling pathways Akt and Erk in both PCa cells. We found that apoptotic markers such as cleaved-PARP protein levels increased significantly in DU145 cells indicating ASE might induce apoptosis. In conclusion, our results suggest that ASE may have the ability to induce PCa cell death through regulating cell cycle arrest and apoptosis pathways.
Keywords: Anchorage-independent growth, Antrodia salmonea, apoptosis, cell cycle, proliferation, prostate cancer
|How to cite this article:|
Cheng PT, Cheng YC, Oner M, Li YH, Chen MC, Wu JH, Chang TC, Celik A, Liu FL, Wang HY, Lai CH, Hsieh JT, Chen CY, Lin H. Antrodia salmonea extract inhibits cell proliferation through regulating cell cycle arrest and apoptosis in prostate cancer cell lines. Chin J Physiol 2022;65:209-14
|How to cite this URL:|
Cheng PT, Cheng YC, Oner M, Li YH, Chen MC, Wu JH, Chang TC, Celik A, Liu FL, Wang HY, Lai CH, Hsieh JT, Chen CY, Lin H. Antrodia salmonea extract inhibits cell proliferation through regulating cell cycle arrest and apoptosis in prostate cancer cell lines. Chin J Physiol [serial online] 2022 [cited 2022 Oct 6];65:209-14. Available from: https://www.cjphysiology.org/text.asp?2022/65/4/209/354799
| Introduction|| |
Prostate cancer (PCa) is caused by abnormal cell proliferation in the prostate. PCa is a highly malignant tumor and the second leading cause of cancer death. The PCa occurrence is initiated with older age in men.,,, It is also related to each person's living habits, eating habits, and family genetic history. It has been known that there are many treatment methods for PCa, such as surgical resection, radiation therapy, chemotherapy, and hormone therapy. In the early stage, androgens and androgen receptor (AR) are required to maintain the proliferation and migration of PCa cells. Therefore, androgen deprivation therapy (ADT) is one of the effective strategies and is usually used as a treatment for early PCa or accompanied by surgical removal of tumor tissue.,,,, However, after ADT, most patients may develop castration-resistant PCa. In this case, the tumor cells appear to be transformed into androgen-independent tumor cells, which are more malignant and aggressive.,,, For these reasons, finding a new drug for PCa treatment becomes a crucial emerging issue.
Antrodia salmonea (AS) is a local fungus belonging to fungal family of Taiwanofungus salmoneus with the features of anti-oxidant, anti-inflammatory, and anticancer. AS has been used to improve the condition of diseases-caused adverse effects, including diarrhea, abdominal pain, hypertension, and itchy skin., It has been reported that AS has a similar biofunction to Antrodia cinnamomea in Taiwan. It has been reported that AS can induce oxidative stress or suppresses tumor growth in ovarian and breast cancer. However, the effect of AS extracts in PCa remains unknown. In this study, we hypothesize that AS can potentially inhibit PCa cell growth through the regulation of cell cycle arrest and apoptosis.
Therefore, we investigated the safe dosage of AS in two PCa cells PC3 and DU145. Next, we evaluated PCa cell growth with the presence of AS treatment. We found that AS extracts inhibited PCa cell growth considering the outcomes from growth rate and anchorage-independent growth. Moreover, we further evaluated cell-cycle-related proteins, apoptotic pathway proteins, and cell growth-related signaling pathways in PCa cell lines. Taken together, our findings suggest that AS is an effective treatment for the inhibition of PCa growth through regulating cell-cycle arrest and apoptosis.
| Materials and Methods|| |
Antrodia salmonea extraction
Depends on the method described previously, the AS was lyophilized by vacuum freeze dryer at −40°C for 72 h. The powder then would be placed in a conical flask with 95% ethanol and sonicated in an ultrasonicator (Branson 5510, Branson Ultrasonic, Ontario, Canada) for 60 min. The extract would then filter with Whatman #1 paper and concentrated in a rotary evaporator and lyophilized.
Reagents and antibodies
Antibodies against to PARP (cat. no. sc-8007, 1:1000), CDK1 (cat. no. sc-54, 1:1500), CDK2 (cat. no. sc-163, 1:1500), cyclin A (cat. no. sc-751, 1:1000), p-Akt (cat. no. sc-7985-R, 1:500), Akt (cat. no. sc-5298, 1:500) were purchased from Santa Cruz Biotechnology. Antibodies against cleaved-PARP (cat. no. AB3565, 1:1000), actin (cat. no. MAB1501, 1:10,000), tubulin (cat. no. #D5-829, 1:15,000) were purchased from Millipore. Antibodies against cyclin B (cat. no. #4138, 1:1000), caspase-8 (cat. No. #9496, 1:1000), p21 (cat. No. 2947s, 1:500), epidermal growth factor receptor (EGFR) (cat. no. #2232, 1:1000), and p-EGFR (cat. no. #2236, 1:1000) were purchased from cell signaling. Antibodies against p27 (cat. no. 610242, 1:500), Erk1 (cat. no. 610031, 1:5000), and p-Erk1/2 (cat. no. 612358, 1:1000) were purchased from BD.
Cell lines and culture
PCa cell lines DU145 and PC3 were purchased from the Center for Bioresource Conservation and Research. The main component of DU145 cell is MEM including 10% fetal bovine serum (FBS, GIBCO), 1% penicillin/streptomycin (P/S, GIBCO), 1.5 g/L sodium bicarbonate (Sigma). PC3 cells were grown in F-12 medium and supplemented with 7% FBS (FBS, GIBCO), 1% penicillin/streptomycin (P/S, GIBCO), and 1.5 g/L sodium bicarbonate (Sigma). The culture environment was incubated at 37°C, 5% CO2, and 95% air, and is subcultured about every 3–4 days.
Trypan blue assay
PC3 and DU145 cells were seeded in 24-wells plate, the seeding number is 8 × 103 cells/well. After 24 h, cells were collected by trypsin, then stained with trypan blue (T8154; Sigma), and counted by hemocytometer.
In 6-well plates, 3 mL of 0.5% agar-growth medium solution with different dosages of Antrodia salmonea extract (ASE) was added to each well as base layers. PC3 cells (8 × 103 cells) were seeded in 1 mL of 0.3% agar-growth medium solution with different dosages of ASE on the top of base layers. The cells were cultured in 37°C for 21 days. Images of colonies were captured at × 4 magnification and quantified by using ImageJ.
Cell protein extraction
The cells were placed on ice to reduce the action of intracellular enzymes, and then collected cells and added lysis buffer, and the cells were mixed for 45 min (15 min/time). Centrifuge at × 15,400 g for 20 min, add Bradford to measure the protein concentration, finally, add the sample buffer, then denature the protein in a dry bath at 100°C for 10 min to perform SDS-PAGE or store at −20°C.
Cell nuclear/cytosolic protein fractionation
The cells were collected in PBS and divided into two groups of input and fraction in a ratio of 2:8. The input group was the same as the method of cell protein extraction. The fraction was added to the hypotonic buffer for 12 min, and then centrifuged for 1500 g for 5 min, and the supernatant was collected for cytoplasmic protein. Moreover, the pellet was further lysed through nuclear extract buffer following by ×15,400 g centrifugation for 20 min to get nuclear protein.
Western blot analysis
Depends on the method described previously, treated cells were collected and lysed by lysis buffer (50 mM Tris-HCL, 150 mM NaCl, 0.5% NP-40, 5 mM EDTA, 10% 2 mM PMSF, and 1% Na3VO4/H2O). The lysates were quantified by Bradford reagent (Sigma-Aldrich, St. Louis, MO, USA) and separated by SDS-PAGE (30 μg/lane). The samples were then transferred onto polyvinylidene difluoride membranes (PerkinElmer Life Sciences, Shelton, CT, USA). The membranes were probed with primary antibodies and incubated with horseradish peroxidase-conjugated secondary antibodies. The protein band on the membrane was revealed by using the Enhanced Chemiluminescence (PerkinElmer Life Sciences, Shelton, CT, USA) reaction and exposed to X-ray films (Fujifilm, Tokyo, Japan) or presented by Luminescence Imaging System LAS-4000 (GE HealthcareLife Sciences, Pittsburgh, PA, USA).
If the magnitude of the experimental results involved different treatment groups, the data of each group were expressed as mean ± standard error and the difference between the two groups was analyzed by t-test two-tailed, with P < 0.05 as a significant difference, and * as a label; P < 0.01 is very different and marked with **;P < 0.001 is a very significant difference and is indicated by ***.
| Results|| |
Antrodia salmonea extract treatment inhibits cell viability of prostate cancer cells
In this study, we first used ASE (6.25–400 μg/mL) to treat PCa PC3 and DU145 cells to examine the cell viability. After 24 h of treatment with ASE, the cell number was assessed by counting under microscopy with trypan blue staining. Our results showed that ASE decreased the cell viability in a dose-dependent manner [Figure 1]a and [Figure 1]b. These data showed that the treatment with ASE in PC3 and DU145 cells decreased the cell proliferation rate.
|Figure 1: ASE inhibited cell viability of prostate cancer cells. (a) PC3 cells were treated with various concentrations of ASE (0, 6.25, 12.5, 25, 50, 100, 200, 400 μg/ml) for 24 h. (b) DU145 cells were treated with various concentrations of ASE (0, 6.25, 12.5, 25, 50, 100, 200, 400 μg/ml) for 24 h. Cell viability was determined by counting with trypan blue staining. Each value is expressed as the mean ± SD (n = 3). Significant at *P < 0.05, **P < 0.01, ***P < 0.001, compared with control. ASE: Antrodia salmonea extract, SD: Standard deviation.|
Click here to view
Antrodia salmonea extract decreases the anchorage-independent growth formation ability in PC3 cells
To further analyze the effects of ASE on the characteristics of cell colony formation, the soft-agar colony assay was performed. After 21 days of treatment with various concentrations of ASE (6.25–100 μg/mL), the colony size of PC3 cells was decreased compared to the control group [Figure 2]a. The quantified results also showed the colony average size decreased with dose-dependent manner compared to the control group [Figure 2]b.
|Figure 2: ASE decreased the anchorage-independent growth formation ability in PC3 cells. (a) PC3 cells were treated with ASE (6.25–100 μg/mL). Colonies were allowed to form for 21 days, then observed by microscope. (b) The colony average size was measured by ImageJ. ASE: Antrodia salmonea extract.|
Click here to view
Antrodia salmonea extract stimulates apoptosis in prostate cancer cells
To understand the mechanism of ASE-inhibited cell viability, PC3 and DU145 cells were treated with ASE (6.25–100 μg/mL) for 24 h to observe the expression level of apoptosis-related proteins. Our results showed that the protein level of cleaved-PARP was increased and total PARP was decreased when PC3 and DU145 were treated with 100 μg/mL ASE [Figure 3]a and [Figure 3]b. These results showed that ASE treatment induced apoptosis in PCa cell.
|Figure 3: ASE induced apoptosis in PC3 and DU145 cells. In (a) PC3 and (b) DU145 cells, protein levels of cleaved-PARP and PARP were analyzed by western blot analysis with different concentrations of ASE treatment (6.25–100 μg/mL). ASE: Antrodia salmonea extract.|
Click here to view
Antrodia salmonea extract decreases cell cycle-related proteins in PC3 and DU145 cells
Next, the cell cycle-related proteins were detected in PC3 and DU145 cells. Here, we used tubulin and PARP as the marker of cytoplasm and nuclear fraction individually. After the treatment with ASE (6.25–100 μg/mL), cyclin B and CDK1, which are important for cell cycle M-phase progression, were decreased in PC3 cells [Figure 4]a. In DU145 cells, ASE treatment decreased cyclin A and CDK2 level, which are responsible for helping cell entry into the S-phase [Figure 4]b. Moreover, the result from cell nuclear/cytosolic protein fractionation in PC3 cell showed that the protein level of CDK1, CDK2 in nuclear also decreased [Figure 4]c. These results indicated that ASE treatment inhibited cell cycle progression through decreased protein levels of cell cycle-related proteins.
|Figure 4: ASE decreased cell cycle-related proteins in PC3 and DU145 cells. (a) In PC3 cells, CDK1 and cyclin B were monitored using western blot analysis. (b) CDK2 and cyclin A have monitored the location in DU145 cells. (c) In PC3 cells, protein levels of cyclin A, CDK1 and CDK2 were analyzed by western blot analysis. ASE: Antrodia salmonea extract.|
Click here to view
Antrodia salmonea extract increases cell cycle inhibitor protein p21 or p27 in PC3 and DU145 cells
Previously, we found that increases of the CDK inhibitor proteins, p21 and p27 in PCa reduced its proliferation ability., Therefore, we investigated how ASE inhibits the cell cycle by evaluating the protein level of cell cycle inhibitor protein p21 and p27. In PC3 cells, AS increased the protein level of p21. In addition, our result from cell nuclear/cytosolic protein fractionation also showed that AS increased the protein stability and protein expression level of p21 but not p27 in nucleus [Figure 5]a. Besides, we also found an increased level of p21 in DU145 cells with the presence of ASE treatment, especially the highest dose of ASE (100 μg/mL) [Figure 5]b. These results indicated that ASE inhibited the cell-cycle by inducing p21 protein expression levels.
|Figure 5: ASE increased cell cycle inhibitor protein p21 in PC3 and DU145 cells In (a) PC3 and (b) DU145 cells, p21 and p27 was monitored for the location using western blot analysis. ASE: Antrodia salmonea extract.|
Click here to view
Antrodia salmonea extract decreases the total protein level of epidermal growth factor receptor and its downstream signaling pathways in PC3 and DU145 cells
Further, the protein level of EGFR and its downstream protein extracellular signal-regulated kinase (Erk) or protein kinase B (Akt) were measured with ASE treatment. Our results showed that ASE decreased the total protein level of phospho-EGFR (Tyr1068), Akt and phospho-Akt in PC3 cells [Figure 6]a. In DU145 cells, ASE decreased the protein level of EGFR, phospho-EGFR, Akt, and phospho-Akt. The protein level of Erk and its phospho-form were also decreased [Figure 6]b. Our data suggested that ASE inhibited the EGFR pathway and further affected Akt or Erk activation in PC3 and DU145 cells.
|Figure 6: ASE decreased the total protein level of EGFR and its downstream signaling pathways in PC3 and DU145 cells Western blotting results showed the effects of ASE on the protein of EGFR and its downstream protein Akt, p-Akt, Erk, p-Erk in (a) PC3 cells and (b) DU145. ASE: Antrodia salmonea extract, EGFR: Epidermal growth factor receptor.|
Click here to view
| Discussion|| |
Over the last few decades, medicinal mushrooms have been found pharmacologically active with biological properties. Some findings have demonstrated that medicinal mushrooms and their bioactive compounds can be potential treatment against various type of human cancers. AS grows with the indigenous coniferous tree Cunninghamia konishii Hayata (Cupressaceae). A. salmonea has recently been reported to have anti-cancer effects as A. cinnamomea does. It has been shown that A. salmonea can inhibit cancer cell growth and enhance cell apoptosis in human triple-negative breast cancer, ovarian carcinoma cells, and human promyelocytic leukemia.,, Since A. salmonea showed beneficial effects against multiple diseases, including the inhibition of cancer cell growth. A. salmonea can be considered as the alternative to A. cinnamomea in the marketplace, because of the rarity and cost in the market.
Therefore, we investigated the anti-cancer effect of the extract of AS on PCa cells. Our current data identified that ASE treatment significantly inhibited the cell viability, and stimulated apoptosis in human PCa cell lines. Apoptosis not only occurs during development and aging, when cells are damaged by noxious agents or stress, but also occurs as a defense mechanism. The occurrence of apoptosis causes cell death. In this study, we found ASE can induce pro-apoptotic protein PARP transfer to cleaved-PARP form to induce apoptosis in human PCa cell line PC3 and DU145.
Cell cycle progression plays an important role in regulating cell proliferation, growth, and cell division. Cancer cell cycle disruption becomes a goal of treatment in the development of new anticancer drugs. CDK2 is activated by cyclin A to drive the transition from S-phase to G2-phase. The combination of cyclin B1 and CDK1 will induce cell cycle progression from the G2 phase to the M phase. Inversely, inhibiting the expression of CDK2, cyclin A or cyclin B1, CDK1 can inhibit cell cycle progression. Since it has been reported that AS induces G2 phase cell cycle arrest and inhibits the cell cycle-related proteins, Cyclin A, Cyclin B1, Cyclin D, Cyclin E, and CDK2 in human triple-negative breast cancer. Therefore, we investigated the role of AS in the regulation of the cell cycle in PCa cells. Our results implied that ASE downregulated the cyclin B, cyclin A, and CDK1, CDK2 expression levels in PCa cells. This finding suggested that AS might be potential inhibitor of S phase or M phase for the treatment of PCa.
The function of p21 in the nucleus is acting as a universal cyclin-dependent kinase inhibitor. It has been found to inhibit all cyclin-CDK complexes. Further, its overexpression inhibits cancer cell proliferation. Besides the essential role of p21 in cell-cycle regulation, p27 can also inhibit cyclin-CDK complexes at G0 to G1 phase. Our current study demonstrated that the protein level of p21 increased in the nuclear in PC3 and DU145 cells. This data suggested ASE may inhibit the cell cycle by increasing p21 but not p27, then further inhibiting cell proliferation. EGFR inhibition suppressed PC3 and DU145 cells growth and motility. Its downstream, Erk and Akt signaling pathways are the molecular mechanisms that are mainly involved in cell survival, proliferation, motility, differentiation, and metabolism. Activation of EGFR promotes its downstream signaling, including MEK/Erk1/2 or PI3K/Akt. Therefore, we monitored EGFR-related signaling pathways in human PCa cell lines. In our study, we found that AS treatment decreased the protein expression level of p-EGFR, p-Akt, and Akt in PC3 cells. Besides, AS also decreased p-EGFR, EGFR, p-Akt, Akt, and p-Erk in DU145 cells. Therefore, we suggest that ASE may decrease PCa cells proliferation through inhibiting EGFR and its downstream proteins.
| Conclusion|| |
Overall, our data suggested that the inhibitory effects of ASE on PCa cells are associated with its ability to inhibit the expressions of cell cycle-related proteins such as CDK1, cyclin B, CDK2, and cyclin A. Moreover, ASE also induced cell cycle inhibitor protein p21 expression level increase. ASE also induces apoptosis by regulating the expressions of PARP and cleaved-PARP. Taken together, AS extract seems to become an effective treatment, and AS can be utilized as a potential drug against human PCa proliferation in the near future.
The authors would like to thank Dr. Shih-Lan Hsu and Ms. Mei-Chun Liu (Department of Medical Research, Taichung Veterans General Hospital, Taiwan) for technical supports.
Financial support and sponsorship
This work was supported by Ministry of Science and Technology (109-2320-B-005-004-MY3 and 109-2911-I-005-003), Taichung Veterans General Hospital and National Chung Hsing University Grant (TCVGH-NCHU-1107608), and Tung's Taichung MetroHarbor Hospital and National Chung Hsing University Grant (TTMHH-NCHULS109005) in Taiwan.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Oner M, Lin E, Chen MC, Hsu FN, Shazzad Hossain Prince GM, Chiu KY, et al
. Future aspects of CDK5 in prostate cancer: From pathogenesis to therapeutic implications. Int J Mol Sci 2019;20:3881.
Helgstrand JT, Røder MA, Klemann N, Toft BG, Brasso K, Vainer B, et al
. Diagnostic characteristics of lethal prostate cancer. Eur J Cancer 2017;84:18-26.
Hsu FN, Chen MC, Chiang MC, Lin E, Lee YT, Huang PH, et al
. Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5. J Biol Chem 2011;286:33141-9.
Lin H, Chen MC, Ku CT. Cyclin-dependent kinase 5 regulates steroidogenic acute regulatory protein and androgen production in mouse Leydig cells. Endocrinology 2009;150:396-403.
Lin H, Juang JL, Wang PS. Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis. J Biol Chem 2004;279:29302-7.
Yue CH, Oner M, Chiu CY, Chen MC, Teng CL, Wang HY, et al
. RET regulates human medullary thyroid cancer cell proliferation through CDK5 and STAT3 activation. Biomolecules 2021;11:860.
Saraon P, Drabovich AP, Jarvi KA, Diamandis EP. Mechanisms of androgen-independent prostate cancer. EJIFCC 2014;25:42-54.
Takayama KI, Suzuki T, Tanaka T, Fujimura T, Takahashi S, Urano T, et al
. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer. Oncogene 2018;37:2165-80.
Tan MH, Li J, Xu HE, Melcher K, Yong EL. Androgen receptor: Structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin 2015;36:3-23.
Cha HR, Lee JH, Ponnazhagan S. Revisiting immunotherapy: A focus on prostate cancer. Cancer Res 2020;80:1615-23.
Heidegger I, Brandt MP, Heck MM. Treatment of non-metastatic castration resistant prostate cancer in 2020: What is the best? Urol Oncol 2020;38:129-36.
Mateo J, Seed G, Bertan C, Rescigno P, Dolling D, Figueiredo I, et al
. Genomics of lethal prostate cancer at diagnosis and castration resistance. J Clin Invest 2020;130:1743-51.
Shorning BY, Dass MS, Smalley MJ, Pearson HB. The PI3K-AKT-mTOR pathway and prostate cancer: At the crossroads of AR, MAPK, and WNT signaling. Int J Mol Sci 2020;21:4507.
Hseu YC, Lee CC, Chen YC, Senthil Kumar KJ, Chen CS, Tsai CT, et al
. Antrodia salmonea
in submerged culture exhibits antioxidant activities in vitro
and protects human erythrocytes and low-density lipoproteins from oxidative modification. Food Chem Toxicol 2014;66:150-7.
Yang HL, Lin RW, Rajendran P, Mathew DC, Thigarajan V, Lee CC, et al
. Antrodia salmonea
-induced oxidative stress abrogates HER-2 signaling cascade and enhanced apoptosis in ovarian carcinoma cells. J Cell Physiol 2019;234:3029-42.
Lu MC, El-Shazly M, Wu TY, Du YC, Chang TT, Chen CF, et al
. Recent research and development of Antrodia cinnamomea
. Pharmacol Ther 2013;139:124-56.
Lin TY, Chen CY, Chien SC, Hsiao WW, Chu FH, Li WH, et al
. Metabolite profiles for Antrodia cinnamomea
fruiting bodies harvested at different culture ages and from different wood substrates. J Agric Food Chem 2011;59:7626-35.
Hsu FN, Yang MS, Lin E, Tseng CF, Lin H. The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells. Am J Physiol Endocrinol Metab 2011;300:E902-8.
Chang CH, Chen MC, Chiu TH, Li YH, Yu WC, Liao WL, et al
. Arecoline promotes migration of A549 lung cancer cells through activating the EGFR/Src/FAK pathway. Toxins (Basel) 2019;11:185.
Huang PH, Chen MC, Peng YT, Kao WH, Chang CH, Wang YC, et al
. Cdk5 directly targets nuclear p21CIP1 and promotes cancer cell growth. Cancer Res 2016;76:6888-900.
Yang HL, Lin RW, Karuppaiya P, Mathew DC, Way TD, Lin HC, et al
. Induction of autophagic cell death in human ovarian carcinoma cells by Antrodia salmonea
through increased reactive oxygen species generation. J Cell Physiol 2019;234:883-94.
Hseu YC, Lee CC, Chen YC, Kumar KJ, Chen CS, Huang YC, et al
. The anti-tumor activity of Antrodia salmonea
in human promyelocytic leukemia (HL-60) cells is mediated via the induction of G1
cell-cycle arrest and apoptosis in vitro
or in vivo. J Ethnopharmacol 2014;153:499-510.
Yang HL, Liu HW, Shrestha S, Thiyagarajan V, Huang HC, Hseu YC. Antrodia salmonea
induces apoptosis and enhances cytoprotective autophagy in colon cancer cells. Aging (Albany NY) 2021;13:15964-89.
Norbury CJ, Hickson ID. Cellular responses to DNA damage. Annu Rev Pharmacol Toxicol 2001;41:367-401.
Shukla S, Fu P, Gupta S. Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70-Bax interaction in prostate cancer. Apoptosis 2014;19:883-94.
Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: A changing paradigm. Nat Rev Cancer 2009;9:153-66.
Chen YK, Wang HC, Ho CT, Chen HY, Li S, Chan HL, et al
. 5-demethylnobiletin promotes the formation of polymerized tubulin, leads to G2/M phase arrest and induces autophagy via JNK activation in human lung cancer cells. J Nutr Biochem 2015;26:484-504.
Abukhdeir AM, Park BH. P21 and p27: Roles in carcinogenesis and drug resistance. Expert Rev Mol Med 2008;10:e19.
Wang S, Wang X, Li J, Meng S, Liang Z, Xu X, et al
. c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3β/Snail signaling in prostate cancer. Oncotarget 2017;8:82303-13.
Zhu C, Zhu Q, Wu Z, Yin Y, Kang D, Lu S, et al
. Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer. J Cell Physiol 2018;233:1104-19.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]